224 related articles for article (PubMed ID: 15908033)
1. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation.
Zeng J; Yang L; Liang Q; Zhang X; Guan H; Xu X; Chen X; Jing X
J Control Release; 2005 Jun; 105(1-2):43-51. PubMed ID: 15908033
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable electrospun fibers for drug delivery.
Zeng J; Xu X; Chen X; Liang Q; Bian X; Yang L; Jing X
J Control Release; 2003 Oct; 92(3):227-31. PubMed ID: 14568403
[TBL] [Abstract][Full Text] [Related]
3. Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation.
Cui W; Li X; Zhu X; Yu G; Zhou S; Weng J
Biomacromolecules; 2006 May; 7(5):1623-9. PubMed ID: 16677047
[TBL] [Abstract][Full Text] [Related]
4. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release.
Liggins RT; Burt HM
Int J Pharm; 2004 Sep; 282(1-2):61-71. PubMed ID: 15336382
[TBL] [Abstract][Full Text] [Related]
6. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
7. Hyperbranched polymers as drug carriers: microencapsulation and release kinetics.
Suttiruengwong S; Rolker J; Smirnova I; Arlt W; Seiler M; Lüderitz L; Pérez de Diego Y; Jansens PJ
Pharm Dev Technol; 2006 Feb; 11(1):55-70. PubMed ID: 16544909
[TBL] [Abstract][Full Text] [Related]
8. Functionalization of electrospun poly(caprolactone) fibers for pH-controlled delivery of doxorubicin hydrochloride.
Jassal M; Sengupta S; Bhowmick S
J Biomater Sci Polym Ed; 2015; 26(18):1425-38. PubMed ID: 26406285
[TBL] [Abstract][Full Text] [Related]
9. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.
Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y
Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922
[TBL] [Abstract][Full Text] [Related]
10. The interplay of membrane formation and drug release in solution-cast films of polylactide polymers.
Ma D; McHugh AJ
Int J Pharm; 2010 Mar; 388(1-2):1-12. PubMed ID: 20025948
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Zhang Z; Feng SS
Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
[TBL] [Abstract][Full Text] [Related]
12. Optimizing partition-controlled drug release from electrospun core-shell fibers.
Tiwari SK; Tzezana R; Zussman E; Venkatraman SS
Int J Pharm; 2010 Jun; 392(1-2):209-17. PubMed ID: 20227472
[TBL] [Abstract][Full Text] [Related]
13. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
14. Solutions for lipophilic drugs: a biodegradable polymer acting as solvent, matrix, and carrier to solve drug delivery issues.
Asmus LR; Gurny R; Möller M
Int J Artif Organs; 2011 Feb; 34(2):238-42. PubMed ID: 21374569
[TBL] [Abstract][Full Text] [Related]
15. Double layer paclitaxel delivery systems based on bioresorbable terpolymer with shape memory properties.
Musiał-Kulik M; Kasperczyk J; Smola A; Dobrzyński P
Int J Pharm; 2014 Apr; 465(1-2):291-8. PubMed ID: 24491529
[TBL] [Abstract][Full Text] [Related]
16. Poly(L-lactide)/halloysite nanotube electrospun mats as dual-drug delivery systems and their therapeutic efficacy in infected full-thickness burns.
Zhang X; Guo R; Xu J; Lan Y; Jiao Y; Zhou C; Zhao Y
J Biomater Appl; 2015 Nov; 30(5):512-25. PubMed ID: 26138705
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kinetics.
Liggins RT; Burt HM
Int J Pharm; 2004 Aug; 281(1-2):103-6. PubMed ID: 15288347
[TBL] [Abstract][Full Text] [Related]
18. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
[TBL] [Abstract][Full Text] [Related]
19. Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system.
Chhabra S; Sachdeva V; Singh S
Int J Pharm; 2007 Sep; 342(1-2):72-7. PubMed ID: 17560056
[TBL] [Abstract][Full Text] [Related]
20. Solid/Hollow depots for drug delivery, part 1: effect of drug characteristics and polymer molecular weight on the phase-inversion dynamics, depot morphology, and drug release.
Liu H; Venkatraman SS
J Pharm Sci; 2014 Feb; 103(2):485-95. PubMed ID: 24357252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
